Genetic Testing Market - Growth, Trends, and Forecasts (2020 - 2025)

The Genetic Testing Market is segmented by Type (Carrier Testing, Diagnostic Testing, Newborn Screening, Predictive and Presymptomatic Testing, Prenatal Testing, and Other Types), Disease (Alzheimer’s Disease, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington's Disease, Rare Diseases, and Other Diseases), Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).

Market Snapshot

Study Period:

2017-2025

Base Year:

2019

Fastest Growing Market:

Asia Pacific

Largest Market:

North America

CAGR:

8.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The genetic testing market has experienced a rapid growth in the past few years. The increasing technological advancements from the past few years have opened several opportunities for market expansion. The rise in the prevalence of chronic diseases and the development of customized testing kits for niche therapeutic areas are aiding the rapid growth of the market.

The increasing focus by governments of various countries, to regulate and create awareness regarding genetic tests, has successfully resulted in the faster adoption of these tests across the world. The increasing R&D funding, along with the strong market presence by major players in the market, has created a strong entry barrier for new entrants. Innovation in product design, improvement in quality, and strong distribution partnerships are key parameters to retain a competitive edge in the market.

The adoption of direct to consumer genetic testing kits in countries, like the United States, China, and Japan, is growing rapidly. With increasing technological adoptions, awareness programs, and a decline in costs, the market for DTC-GT (Direct-to-consumer genetic testing) kits is likely to witness a significant boost over the forecast period. Moreover, the untapped countries, like India and other developing countries, are expected to offer a lucrative opportunity for players looking to establish their base in the genetic testing market.

Scope of the Report

As per the scope of the report, genetic test is performed to identify the presence of a particular gene, with a particular sequence of the genome. The gene can be identified either directly through sequencing or indirectly through various methods. Genetic testing practices are rapidly increasing in rare disease diagnostics and for personalized medicines, which, in turn, is fueling the growth of the market studied.

By Type
Carrier Testing
Diagnostic Testing
Newborn Screening
Predictive and Presymptomatic Testing
Prenatal Testing
Other Types
By Disease
Alzheimer’s Disease
Cancer
Cystic Fibrosis
Sickle Cell Anemia
Duchenne Muscular Dystrophy
Thalassemia
Huntington’s Disease
Rare Diseases
Other Diseases
By Technology
Cytogenetic Testing
Biochemical Testing
Molecular Testing
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle-East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Application in Cancer is Expected to Dominate the Market

  • Genetic testing helps estimate the chance of developing cancer in a person's lifetime. It does this by searching for specific changes in genes, chromosomes, or proteins. Moreover, it helps in predicting risk of a particular type of cancer in a person and finding whether genes that may pass increased cancer risk to its next generation.
  • The global incidence of cancer is high and is expected to increase in future as well. Cancer Research UK 2018 data suggests that if recent trends in the incidence of major cancers and population growth are consistent, then it is expected that there may be 27.5 million new cancer cases across the world, annually, by 2040. This is an increase of 61.7% from 2018 (17 million new cases).
  • Increase in number of cancer cases is expected to increase the demand for genetic testing kits for early detection. This is likely to help the market growth.

To understand key trends, Download Sample Report

North America Captured the Largest Market Share and is Expected to Retain its Dominance

  • Currently, North America dominates the market for genetic testing, owing to factors, like increasing demand for personalized genetic testing services in the region and rise in the prevalence of chronic and genetic disorders.
  • In the United States, two federal agencies have the primary authority to regulate genetic tests, the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS). In the past, the Federal Trade Commission (FTC) has also played a role in regulating genetic testing companies, who advertised false and misleading claims about their products, but this agency currently plays a minor role in this space.​ 
  • The popular direct-to-customer genetic testing (DTC-GT) services available in the United States include those offered by 23&Me. These genetic testing services are largely unregulated, due to their mode of sales operation viz online marketplace.
  • In the developing regions, like Mexico, market players from neighboring countries, like United States, are penetrating the Mexican market, exploring untapped opportunities. Therefore, these factors are expected to help the growth in the North American region in the future.

To understand geography trends, Download Sample Report.

Competitive Landscape

The genetic testing market is highly competitive and consists several major players. In terms of market share, few of the major players currently dominate the market. The presence of major market players, such as Abbott Laboratories, BioRad Laboratories Inc., F Hoffmann-La Roche, and Illumina Inc., is in turn, increasing the overall competitive rivalry of the market. The product advancements and improvements in genetic testing platforms by the major players are increasing competitive rivalry.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Emphasis on Early Disease Detection and Prevention

      2. 4.2.2 Growing Demand for Personalized Medicine

      3. 4.2.3 Increasing Application of Genetic Testing in Oncology

    3. 4.3 Market Restraints

      1. 4.3.1 High Costs of Genetic Testing

      2. 4.3.2 Social and Ethical Implications of Genetic Testing

    4. 4.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Carrier Testing

      2. 5.1.2 Diagnostic Testing

      3. 5.1.3 Newborn Screening

      4. 5.1.4 Predictive and Presymptomatic Testing

      5. 5.1.5 Prenatal Testing

      6. 5.1.6 Other Types

    2. 5.2 By Disease

      1. 5.2.1 Alzheimer’s Disease

      2. 5.2.2 Cancer

      3. 5.2.3 Cystic Fibrosis

      4. 5.2.4 Sickle Cell Anemia

      5. 5.2.5 Duchenne Muscular Dystrophy

      6. 5.2.6 Thalassemia

      7. 5.2.7 Huntington’s Disease

      8. 5.2.8 Rare Diseases

      9. 5.2.9 Other Diseases

    3. 5.3 By Technology

      1. 5.3.1 Cytogenetic Testing

      2. 5.3.2 Biochemical Testing

      3. 5.3.3 Molecular Testing

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East & Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East & Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 23&Me Inc.

      2. 6.1.2 Abbott Laboratories

      3. 6.1.3 BioRad Laboratories Inc.

      4. 6.1.4 Danaher Corporation (Cepheid Inc.)

      5. 6.1.5 F Hoffmann-La Roche AG

      6. 6.1.6 Illumina Inc.

      7. 6.1.7 Luminex Corporation

      8. 6.1.8 Myriad Genetics Inc.

      9. 6.1.9 PerkinElmer Inc.

      10. 6.1.10 Quest Diagnostics Incorporated

  7. *List Not Exhaustive
  8. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports